vs
STANDARD BIOTOOLS INC.（LAB）与Spire Global, Inc.（SPIR）财务数据对比。点击上方公司名可切换其他公司
STANDARD BIOTOOLS INC.的季度营收约是Spire Global, Inc.的1.2倍（$19.6M vs $15.8M），Spire Global, Inc.净利率更高（-176.6% vs -177.4%，领先0.8%），STANDARD BIOTOOLS INC.同比增速更快（-11.5% vs -26.9%），Spire Global, Inc.自由现金流更多（$-16.2M vs $-23.1M），过去两年STANDARD BIOTOOLS INC.的营收复合增速更高（-12.2% vs -32.6%）
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
Spire Global, Inc.是一家天基云数据与分析服务企业，核心业务依托由大量纳米卫星组成的卫星星座，提供覆盖全球的多领域数据集追踪服务，具体包含船舶航运追踪、航空航行监控以及气象模式观测等相关业务，服务覆盖全球范围。
LAB vs SPIR — 直观对比
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $19.6M | $15.8M |
| 净利润 | $-34.7M | $-28.0M |
| 毛利率 | 48.5% | 40.2% |
| 营业利润率 | -168.5% | -164.1% |
| 净利率 | -177.4% | -176.6% |
| 营收同比 | -11.5% | -26.9% |
| 净利润同比 | -28.8% | 42.7% |
| 每股收益（稀释后） | $-0.09 | $-0.85 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | — | $15.8M | ||
| Q3 25 | $19.6M | $12.7M | ||
| Q2 25 | $21.8M | $19.2M | ||
| Q1 25 | $40.8M | $23.9M | ||
| Q4 24 | — | $21.7M | ||
| Q3 24 | $22.1M | $28.6M | ||
| Q2 24 | $22.5M | $25.4M | ||
| Q1 24 | $45.5M | $34.8M |
| Q4 25 | — | $-28.0M | ||
| Q3 25 | $-34.7M | $-19.7M | ||
| Q2 25 | $-33.5M | $119.6M | ||
| Q1 25 | $-26.0M | $-20.7M | ||
| Q4 24 | — | $-48.8M | ||
| Q3 24 | $-26.9M | $-12.5M | ||
| Q2 24 | $-45.7M | $-16.6M | ||
| Q1 24 | $-32.2M | $-25.5M |
| Q4 25 | — | 40.2% | ||
| Q3 25 | 48.5% | 36.6% | ||
| Q2 25 | 48.8% | 48.9% | ||
| Q1 25 | 48.4% | 36.8% | ||
| Q4 24 | — | 32.4% | ||
| Q3 24 | 54.9% | 44.5% | ||
| Q2 24 | 46.1% | 43.0% | ||
| Q1 24 | 53.1% | 26.5% |
| Q4 25 | — | -164.1% | ||
| Q3 25 | -168.5% | -166.1% | ||
| Q2 25 | -118.1% | -122.7% | ||
| Q1 25 | -80.8% | -106.5% | ||
| Q4 24 | — | -144.1% | ||
| Q3 24 | -120.9% | -48.0% | ||
| Q2 24 | -134.5% | -48.6% | ||
| Q1 24 | -132.2% | -34.4% |
| Q4 25 | — | -176.6% | ||
| Q3 25 | -177.4% | -155.3% | ||
| Q2 25 | -153.7% | 623.4% | ||
| Q1 25 | -63.8% | -86.5% | ||
| Q4 24 | — | -225.2% | ||
| Q3 24 | -122.0% | -43.7% | ||
| Q2 24 | -203.3% | -65.2% | ||
| Q1 24 | -70.6% | -73.3% |
| Q4 25 | — | $-0.85 | ||
| Q3 25 | $-0.09 | $-0.61 | ||
| Q2 25 | $-0.09 | $3.72 | ||
| Q1 25 | $-0.07 | $-0.77 | ||
| Q4 24 | — | $-1.93 | ||
| Q3 24 | $-0.07 | $-0.50 | ||
| Q2 24 | $-0.12 | $-0.68 | ||
| Q1 24 | $-0.27 | $-1.17 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $129.4M | $81.8M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $399.7M | $112.9M |
| 总资产 | $539.6M | $211.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | — | $81.8M | ||
| Q3 25 | $129.4M | $96.8M | ||
| Q2 25 | $158.6M | $117.6M | ||
| Q1 25 | $150.9M | $35.9M | ||
| Q4 24 | — | $19.2M | ||
| Q3 24 | $210.6M | $36.6M | ||
| Q2 24 | $269.8M | $45.8M | ||
| Q1 24 | $287.1M | $63.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $103.7M | ||
| Q4 24 | — | $103.1M | ||
| Q3 24 | $55.2M | $4.9M | ||
| Q2 24 | $55.1M | $4.9M | ||
| Q1 24 | $55.0M | $123.1M |
| Q4 25 | — | $112.9M | ||
| Q3 25 | $399.7M | $133.1M | ||
| Q2 25 | $424.5M | $149.2M | ||
| Q1 25 | $454.6M | $3.7M | ||
| Q4 24 | — | $-11.7M | ||
| Q3 24 | $489.3M | $30.8M | ||
| Q2 24 | $510.3M | $40.3M | ||
| Q1 24 | $577.3M | $52.5M |
| Q4 25 | — | $211.0M | ||
| Q3 25 | $539.6M | $224.3M | ||
| Q2 25 | $557.0M | $239.5M | ||
| Q1 25 | $579.6M | $208.8M | ||
| Q4 24 | — | $193.6M | ||
| Q3 24 | $681.5M | $224.2M | ||
| Q2 24 | $708.7M | $230.8M | ||
| Q1 24 | $777.7M | $252.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 27.92× | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.11× | 0.16× | ||
| Q2 24 | 0.11× | 0.12× | ||
| Q1 24 | 0.10× | 2.35× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-22.2M | $-4.3M |
| 自由现金流经营现金流 - 资本支出 | $-23.1M | $-16.2M |
| 自由现金流率自由现金流/营收 | -118.1% | -102.1% |
| 资本支出强度资本支出/营收 | 4.5% | 75.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-111.1M | $-92.6M |
8季度趋势，按日历期对齐
| Q4 25 | — | $-4.3M | ||
| Q3 25 | $-22.2M | $-12.0M | ||
| Q2 25 | $-20.7M | $-35.1M | ||
| Q1 25 | $-30.3M | $-8.4M | ||
| Q4 24 | — | $-19.2M | ||
| Q3 24 | $-27.9M | $14.0M | ||
| Q2 24 | $-39.0M | $-4.4M | ||
| Q1 24 | $-62.5M | $-8.8M |
| Q4 25 | — | $-16.2M | ||
| Q3 25 | $-23.1M | $-20.4M | ||
| Q2 25 | $-22.6M | $-38.7M | ||
| Q1 25 | $-35.3M | $-17.3M | ||
| Q4 24 | — | $-24.3M | ||
| Q3 24 | $-30.1M | $5.1M | ||
| Q2 24 | $-41.0M | $-9.9M | ||
| Q1 24 | $-63.3M | $-15.9M |
| Q4 25 | — | -102.1% | ||
| Q3 25 | -118.1% | -161.3% | ||
| Q2 25 | -103.6% | -201.7% | ||
| Q1 25 | -86.6% | -72.6% | ||
| Q4 24 | — | -112.2% | ||
| Q3 24 | -136.4% | 17.8% | ||
| Q2 24 | -182.2% | -39.0% | ||
| Q1 24 | -138.9% | -45.7% |
| Q4 25 | — | 75.1% | ||
| Q3 25 | 4.5% | 66.2% | ||
| Q2 25 | 8.7% | 18.8% | ||
| Q1 25 | 12.4% | 37.3% | ||
| Q4 24 | — | 23.5% | ||
| Q3 24 | 10.2% | 31.2% | ||
| Q2 24 | 8.6% | 21.8% | ||
| Q1 24 | 1.7% | 20.3% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -0.29× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
SPIR
暂无分部数据
